Interventions for cutaneous sarcoidosis (Protocol)

[1]  A. Prasse,et al.  Sarcoidosis , 2014, The Lancet.

[2]  Kristian Thorlund,et al.  How to use an article reporting a multiple treatment comparison meta-analysis. , 2012, JAMA.

[3]  M. Judson,et al.  Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. , 2012, Journal of the American Academy of Dermatology.

[4]  K. Kerr,et al.  Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries , 2011, Journal of Clinical Pathology.

[5]  R. Baughman,et al.  Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. , 2010, Chest.

[6]  Miguel Sanchez,et al.  Sarcoidosis of the skin: a review for the pulmonologist. , 2009, Chest.

[7]  Frank A Santoro,et al.  Nail dystrophy and bony involvement in chronic sarcoidosis. , 2009, Journal of the American Academy of Dermatology.

[8]  O. Sharma.  Sarcoidosis around the world. , 2008, Clinics in chest medicine.

[9]  D. Cella,et al.  Quality of life evaluation in sarcoidosis: current status and future directions , 2008, Current opinion in pulmonary medicine.

[10]  B. Esmaeli,et al.  Orbital and adnexal sarcoidosis. , 2007, Archives of ophthalmology.

[11]  R. Baughman,et al.  Evidence-based therapy for cutaneous sarcoidosis. , 2007, Clinics in dermatology.

[12]  T. Lasserson,et al.  Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. , 2006, The Cochrane database of systematic reviews.

[13]  J. Callejas-Rubio,et al.  Treatment of therapy-resistant sarcoidosis with adalimumab , 2006, Clinical Rheumatology.

[14]  J. Callen,et al.  Development of sarcoidosis in cosmetic tattoos. , 2005, Archives of dermatology.

[15]  P. Jones,et al.  Corticosteroids for pulmonary sarcoidosis. , 2005, The Cochrane database of systematic reviews.

[16]  C. Lebbé,et al.  Treatment of cutaneous sarcoidosis with thalidomide. , 2004, Journal of the American Academy of Dermatology.

[17]  A. Shorr,et al.  The use of infliximab in cutaneous sarcoidosis. , 2003, Journal of drugs in dermatology : JDD.

[18]  M. Parmar,et al.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.

[19]  J. Peyri,et al.  Cutaneous involvement in sarcoidosis. Relationship to systemic disease. , 1997, Archives of dermatology.

[20]  K. Khatri,et al.  Lupus pernio: successful treatment with a potent topical corticosteroid. , 1995, Archives of dermatology.

[21]  J. Zic,et al.  Treatment of cutaneous sarcoidosis with chloroquine. Review of the literature. , 1991, Archives of dermatology.

[22]  J. Callen,et al.  Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. , 1990, Journal of the American Academy of Dermatology.

[23]  M. Elgart.  Cutaneous sarcoidosis: definitions and types of lesions. , 1986, Clinics in dermatology.

[24]  C. L. Schamroth,et al.  Sarcoid dactylitis in black South African patients. , 1985, Seminars in arthritis and rheumatism.

[25]  G. Hutchins,et al.  Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.

[26]  Susan C. Taylor,et al.  Sarcoidosis: Are there differences in your skin of color patients? , 2012, Journal of the American Academy of Dermatology.

[27]  T. Rosen,et al.  Evidence-Based Therapy for Cutaneous Sarcoidosis , 2012, Drugs.

[28]  H. Oiwa,et al.  Psoriasiform plaques of sarcoidosis. , 2009, Internal medicine.

[29]  Christy Badgwell,et al.  Cutaneous sarcoidosis therapy updated. , 2007, Journal of the American Academy of Dermatology.

[30]  L. Dubertret,et al.  The use of tetracyclines for the treatment of sarcoidosis. , 2001, Archives of dermatology.

[31]  J. Scadding,et al.  Sarcoidosis of the skin , 1985 .